Core Viewpoint - Intuitive Surgical's stock has declined approximately 30% from its 52-week high, presenting a potential buying opportunity for investors interested in growth stocks within the medical-device sector [1] Group 1: Company Overview - Intuitive Surgical is a leader in surgical robotics, particularly known for its da Vinci surgical robot system, which enhances surgical safety and patient outcomes through less invasive procedures [2][3] - The company continues to see growth in the deployment of da Vinci systems, with 395 new systems placed in the second quarter of 2025, a 15.8% increase from 341 in the same period last year, bringing the total to 10,488 systems, a 14% year-over-year increase [4][5] Group 2: Revenue Sources - The primary revenue for Intuitive Surgical comes from consumable items used in surgeries, which account for approximately 60% of sales, while the sale of robots contributes less than 25% to the top line [6][7] - Services related to installation and maintenance of da Vinci systems also contribute to revenue, creating a recurring income model that is beneficial for the company [8] Group 3: Stock Valuation - Intuitive Surgical's current price-to-sales ratio is around 17x and its price-to-earnings ratio is nearly 60x, indicating a high valuation compared to traditional value investment metrics [9] - The company's five-year average price-to-sales ratio is approximately 18.6x, and the average price-to-earnings ratio is about 72.5x, suggesting that while the stock is not cheap, it is relatively cheaper than in the past [11] - Historical data shows that a 30% drawdown in stock price is not unusual, which may attract more aggressive growth investors [11][12]